2026 Pharma & Medtech Symposium
To receive CLE credit, please complete the Evaluation Form below.
Tuesday, June 2
8 a.m. - 1 p.m. EDT
Porzio Offices, 5 Sylvan Way, Parsippany, NJ
About the Symposium
If you have any questions, please contact [email protected].
Join Porzio’s legal team, industry thought leaders, and regulatory experts for an exclusive symposium focused on the evolving legal and compliance landscape in the life sciences sector. This event will offer in-depth insights into the complexities of direct-to-consumer (DTC) advertising, patient advocacy, and consumer interactions.
Topics Include:
- Highlights from recent enforcement and related healthcare compliance developments
- Best practices for policies and SOPs addressing patient-related engagement
- Liability considerations for patient-directed activities
- Promotional review panel discussion: DTC advertising and social media
Agenda
8 a.m.
Registration & Breakfast
9 a.m.
Welcome Remarks
Vito A. Gagliardi, Jr., Managing Principal, Porzio, Bromberg & Newman
9:05 a.m.
Highlights from Recent Enforcement and Related Healthcare Compliance Developments
Jen Romanski, Principal, Porzio, Bromberg & Newman
Noah Goldstein, Counsel, Porzio, Bromberg & Newman
A practical overview of recent enforcement actions, regulatory trends, and compliance developments impacting life sciences companies. Attendees will gain insight into government priorities and key takeaways to help mitigate risk and strengthen compliance programs.
9:50 a.m.
Best Practices for Policies/SOPs Addressing Patient-Related Interactions and Engagement
Michelle Axelrod, Principal, Porzio, Bromberg & Newman
This session will explore best practices for developing and updating policies and SOPs governing patient engagement, including advocacy interactions, support programs, and communications. Learn how to balance innovation, transparency, and compliance in an increasingly patient‑focused environment.
10:35 a.m.
Break
10:50 a.m.
Liability Considerations for Patient-Directed Activities
Martin J. Healy, Principal, Porzio, Bromberg & Newman
Rebecca Wall Forrestal, Counsel, Porzio, Bromberg & Newman
An examination of potential liability risks associated with patient‑directed initiatives, including promotional activities, support services, and data use. This session will provide practical strategies to identify exposures early and structure programs to reduce legal and regulatory risk.
11:30 a.m.
Promotional Review Panel Discussion: DTC Advertising and Social Media
Jennifer A. Romanski, Principal, Porzio, Bromberg & Newman
Vaughn Klug, Director, Corporate Counsel, NA Legal & Compliance, Leo Pharma
Nneoma Nwadike, PharmD, RPh, Associate Director, Regulatory Affairs, Advertising & Promotion, Supernus
Radha Kadiwar, NJ Registered Pharmacist, Director, US Medical Affairs, CSL Seqirus
A dynamic, cross‑functional discussion addressing real‑world challenges in DTC advertising and social media. Panelists will share perspectives from legal, regulatory, and medical review, offering practical guidance on navigating review processes, emerging platforms, and evolving FDA expectations.
12:30 p.m.
Closing Remarks
Jennifer A. Romanski, Principal, Porzio, Bromberg & Newman